BOLT (boltbio.com) Sof foyda

BOLT (boltbio.com) - kompaniyaning tovar belgisi

Bolt Biotherapeutics daromadliligi logistik murakkabliklar va Osiyodagi patent nizolari tufayli cheklangan. Kompaniyaning yillik sof foydasi joriy samaradorlikni aniq ko'rsatadi, bunda -0.03 belgisi ushbu parametrni xarakterlaydi. Roche bilan hamkorlik va ISAC dori sinovlari aksiyalar narxining o'sishiga turtki bermoqda. Biroq, tor onkologiya pipeline-ga yuqori bog'liqlik binar xatarlarni yuzaga keltirmoqda, bu esa yirik farmatsevtika hamkorlarining qo'llab-quvvatlashi bilan yumshatiladi.

BOLT (Bolt Biotherapeutics) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

boltbio.com (BOLT) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Bolt Biotherapeutics, Inc.|BOLT - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Bolt Biotherapeutics|BOLT - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Bolt Biotherapeutics|BOLT - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi boltbio.com|BOLT - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Bolt Biotherapeutics|BOLT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics, Inc.|BOLT - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Bolt Biotherapeutics|BOLT - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Bolt Biotherapeutics|Shoshilinch likvidlik boltbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
BOLT - Sof foyda
Kompaniyaning jamlanma tahlili:Bolt Biotherapeutics
Bolt Biotherapeutics Inc. asosiy tovari

Bolt Biotherapeutics (BOLT) kompaniyasining umumiy moliyaviy natijalari barcha operatsion xarajatlar chegirib tashlangan holda, biotexnologik ishlanmalarni monetizatsiya qilish samaradorligini aks ettiradi. Ushbu ko'rsatkich tadqiqot va ishlanmalar (R&D) xarajatlarini qoplashdan keyin qolgan sof mablag'larni o'lchaydi, bunda klinik sinovlar uchun kapitalning yuqori sarf tezligi va terapiya natijalarining noaniqligi bevosita foydaning tebranishlarini hamda aktivning umumiy investitsiya barqarorligini belgilaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR: Kompaniyaning sof foydasi|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi upstreambio.com (UPB)|Kompaniyaning sof foydasi Zenas Biopharma|Kompaniyaning sof foydasi IMNM|Sof daromad GOSS (Gossamer Corp)|Soliqlar to‘langandan keyingi foyda KALV|Septerna Inc - Sof daromad|Yakuniy foyda PVLA|Savara - Sof foyda|RIGL: Kompaniyaning sof foydasi|ANAB: Sof foyda|ATXS - Sof moliyaviy natija|Kompaniyaning sof foydasi enGene Holdings Inc.|Kompaniyaning sof daromadi rapt.com RAPT|Sof daromad JBIO (Aerovate Therapeutics Inc)|Soliqlar to‘langandan keyingi foyda ACRS|Sof foyda KYTX (Kyverna)|Yakuniy foyda TLSA|Cabaletta Bio, Inc. - Sof foyda|Kompaniyaning sof daromadi ventyxbio.com|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Avalo Therapeutics, Inc. - Yakuniy foyda|ELDN (Eledon) - Sof foyda|Sof foyda Agenus, Inc|Kompaniyaning sof foydasi Climb Bio Inc (CLYM)|ZURA: Soliqdan keyingi foyda|Sof foyda ATYR (aTyr Pharma)|Adagene Inc (ADAG) - Kompaniyaning sof daromadi|IMA: Sof daromad|STTK - Sof foyda|EQ (equilliumbio.com) - Sof daromad|CNTB: Soliqlar to‘langandan keyingi foyda|IMUX (Immunic Therapeutics) - Sof foyda|Atara Biotherapeutics Inc (ATRA) - Sof moliyaviy natija|Sof foyda IFRX|Sof daromad X4 Pharmaceuticals, Inc XFOR|Kompaniyaning sof foydasi Adicet Bio, Inc. ACET|Sof moliyaviy natija Celularity Inc (CELU)|INmune Bio - Sof foyda|BRNS: Kompaniyaning sof foydasi|Kezar Life Sciences, Inc (KZR) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi SAB Biotherapeutics Inc (SABS)|Kompaniyaning sof foydasi Akari Therapeutics|Kompaniyaning sof foydasi ENLV|Sof daromad QTTB (Q32 Bio Inc.)|Soliqlar to‘langandan keyingi foyda GOVX|Kompaniyaning sof foydasi Edesa EDSA|IBIO (iBio Corporation) - Soliqdan keyingi foyda|Carisma Tx - Sof foyda|Yakuniy foyda XTLB (xtlbio.com)|HCWB: Sof foyda|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Kompaniyaning sof foydasi AIM ImmunoTech|ADTX: Yakuniy foyda|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof daromad xortx.com XRTX|Sof foyda HIND (Vyome Holdings)|Sof foyda Revelation Biosciences Inc REVB|INDP: Sof daromad|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|AFMD - Sof moliyaviy natija|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Ocean Biomedical, Inc. - Sof daromad|Sof foyda tcbiopharm.com TCBP|THRD - Kompaniyaning sof foydasi